Related Articles
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia
Dynein axonemal heavy chain 9 M4374I variation may have an effect on imatinib mesylate resistance in CML
BCR-ABL- and Ras-independent activation of Raf as a novel mechanism of Imatinib resistance in CML
Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib
Hsp90 inhibitor, BIIB021, induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells